GCC HIV Drugs Market

1 Introduction
    1.1    Research Objectives 
    1.2    Stakeholders
    1.3    Scope of the Report
    1.4    Assumptions and Limitations
2 Research Methodology 
    2.1    Data Collection
            2.1.1    Primary Sources
            2.1.2    Secondary Sources
    2.2    Market Size Estimation
            2.2.1    Bottom-Up Approach
            2.2.2    Top-Down Approach
    2.3    Data Validation
3 Executive Summary
4 Global HIV Drugs Market
    4.1    Historical Market Trend
    4.2    Market Segmentation by Region
    4.3    Market Outlook
5 GCC HIV Drugs Market
    5.1    Industry Overview 
    5.2    Key Industry Developments
    5.3    Market Trends
            5.3.1    Key Market Indicators
            5.3.2    Historical Market Trends
            5.3.3    Impact of COVID-19
            5.3.4    Market Outlook
6 GCC HIV Drugs Market Segmentation by Country
    6.1    Saudi Arabia  
            6.1.1    Historical Market Trends
            6.1.2    Market Outlook
    6.2    United Arab Emirates   
            6.2.1    Historical Market Trends
            6.2.2    Market Outlook
    6.3    Qatar 
            6.3.1    Historical Market Trends
            6.3.2    Market Outlook
    6.4    Kuwait 
            6.4.1    Historical Market Trends
            6.4.2    Market Outlook
    6.5    Oman  
            6.5.1    Historical Market Trends
            6.5.2    Market Outlook
    6.6    Bahrain  
            6.6.1    Historical Market Trends
            6.6.2    Market Outlook
7 GCC HIV Drugs Market Segmentation by Drug Class
    7.1    Nucleoside Reverse Transcriptase Inhibitors
            7.1.1    Historical Market Trends
            7.1.2    Market Outlook
    7.2    Multi-Class Combination Products
            7.2.1    Historical Market Trends
            7.2.2    Market Outlook
    7.3    Protease Inhibitors
             7.3.1    Historical Market Trends
             7.3.2    Market Outlook
    7.4    HIV Integrase Strand Transfer Inhibitors
             7.4.1    Historical Market Trends
             7.4.2    Market Outlook
    7.5    Non-Nucleoside Reverse Transcriptase Inhibitors 
            7.5.1    Historical Market Trends
            7.5.2    Market Outlook
    7.6    Entry Inhibitors — CCR5 Co-Receptor Antagonist
             7.6.1    Historical Market Trends
             7.6.2    Market Outlook
    7.7    Fusion Inhibitors
             7.7.1    Historical Market Trends
             7.7.2    Market Outlook
8 GCC HIV Drugs Market Segmentation by Distribution Channel
    8.1    Hospital Pharmacies
             8.1.1    Historical Market Trends
             8.1.2    Market Outlook
    8.2    Retail Pharmacies    
             8.2.1    Historical Market Trends
             8.2.2    Market Outlook
    8.3    Online Pharmacies
             8.3.1    Historical Market Trends
             8.3.2    Market Outlook
    8.4   Others    
            8.4.1    Historical Market Trends
            8.4.2    Market Outlook
9 GCC HIV Drugs Industry: Market Dynamics
    9.1    Overview
    9.2    Strengths
    9.3    Weaknesses 
    9.4    Opportunities
    9.5    Threats
10 GCC HIV Drugs Industry: Value Chain Analysis
    10.1   Overview
    10.2   Research and Development
    10.3   Raw Material Suppliers
    10.4   Inbound Logistics
    10.5   Production
    10.6   Marketing 
    10.7   Outbound Logistics
    10.8   Consumers 
11 GCC HIV Drugs Industry: Porter’s Five Forces Analysis
    11.1   Overview
    11.2   Threat of New Entrants
    11.3   Threat of Substitutes
    11.4   Bargaining Power of Buyers
    11.5   Bargaining Power of Suppliers
    11.6   Intensity of Rivalry
12 Competitive Landscape
    12.1   Market Structure
    12.2   Key Players 
    12.3   Key Success Factors 
13 Key Player Profiles
 
List of Figures

Figure 1: Global: HIV Drugs Market: Sales Value (in Billion US$), 2017-2022
Figure 2: Global: HIV Drugs Market: Segmentation by Region (in %), 2022
Figure 3: Global: HIV Drugs Market Outlook: Sales Value (in Billion US$), 2023-2028
Figure 4: GCC: HIV Drugs Market: Sales Value (in Billion US$), 2017-2022
Figure 5: GCC: HIV Drugs Market Outlook: Sales Value (in Billion US$), 2023-2028
Figure 6: GCC: HIV Drugs Market: Segmentation by Country (in %), 2022
Figure 7: GCC: HIV Drugs Market: Segmentation by Drug Class (in %), 2022
Figure 8: GCC: HIV Drugs Market: Segmentation by Distribution Channel (in %), 2022
Figure 9: Saudi Arabia: HIV Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Saudi Arabia: HIV Drugs Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 11: United Arab Emirates: HIV Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: United Arab Emirates: HIV Drugs Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 13: Qatar: HIV Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Qatar: HIV Drugs Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 15: Kuwait: HIV Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Kuwait: HIV Drugs Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 17: Oman: HIV Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Oman: HIV Drugs Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 19: Bahrain: HIV Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Bahrain: HIV Drugs Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 21: GCC: HIV Drugs (Nucleoside Reverse Transcriptase Inhibitors) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: GCC: HIV Drugs (Nucleoside Reverse Transcriptase Inhibitors) Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 23: GCC: HIV Drugs (Multi-Class Combination Products) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: GCC: HIV Drugs (Multi-Class Combination Products) Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 25: GCC: HIV Drugs (Protease Inhibitors) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: GCC: HIV Drugs (Protease Inhibitors) Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 27: GCC: HIV Drugs (HIV Integrase Strand Transfer Inhibitors) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: GCC: HIV Drugs (HIV Integrase Strand Transfer Inhibitors) Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 29: GCC: HIV Drugs (Non-Nucleoside Reverse Transcriptase Inhibitors) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: GCC: HIV Drugs (Non-Nucleoside Reverse Transcriptase Inhibitors) Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 31: GCC: HIV Drugs (Entry Inhibitors — CCR5 Co-Receptor Antagonist) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: GCC: HIV Drugs (Entry Inhibitors — CCR5 Co-Receptor Antagonist) Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 33: GCC: HIV Drugs (Fusion Inhibitors) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: GCC: HIV Drugs (Fusion Inhibitors) Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 35: GCC: HIV Drugs (Hospital Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: GCC: HIV Drugs (Hospital Pharmacies) Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 37: GCC: HIV Drugs (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: GCC: HIV Drugs (Retail Pharmacies) Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 39: GCC: HIV Drugs (Online Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: GCC: HIV Drugs (Online Pharmacies) Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 41: GCC: HIV Drugs (Others) Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: GCC: HIV Drugs (Others) Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 43: GCC: HIV Drugs Industry: Market Dynamics
Figure 44: GCC: HIV Drugs Industry: Value Chain Analysis
Figure 45: GCC: HIV Drugs Market: Porter’s Five Forces Analysis
 
List of Tables

Table 1: GCC: HIV Drugs Market: Key Industry Highlights, 2022 and 2028
Table 2: GCC: HIV Drugs Market Outlook: Segmentation by Country (in Million US$), 2023-2028
Table 3: GCC: HIV Drugs Market Outlook: Segmentation by Drug Class (in Million US$), 2023-2028
Table 4: GCC: HIV Drugs Market Outlook: Segmentation by Distribution Channel (in Million US$), 2023-2028
Table 5: GCC: HIV Drugs Market Structure
Table 6: GCC: HIV Drugs Market: Key Players